Catabasis Pharmaceutical is categorized under Wholesale Pharmaceutical Products in Cambridge, MA and active since 2010.
Catabasis Pharmaceutical was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Oliver S Fetzer at the company’s single location by writing to 840 Memorial Drive # 5, Cambridge, Massachusetts MA 02139 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Catabasis Pharmaceutical |
| Contact Person: | Oliver S Fetzer |
| Address: | 840 Memorial Drive # 5, Cambridge, Massachusetts 02139 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Catabasis Pharmaceutical was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Oliver S Fetzer for inquiries that concern Catabasis Pharmaceutical by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Catabasis Pharmaceutical can be found at the coordinates as well as the street address 840 Memorial Drive # 5 in Cambridge, Massachusetts 02139.
For its online presence, you may visit Catabasis Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.